Literature DB >> 19737791

Diagnostic change and the increased prevalence of autism.

Marissa King1, Peter Bearman.   

Abstract

BACKGROUND: Increased autism prevalence rates have generated considerable concern. However, the contribution of changes in diagnostic practices to increased prevalence rates has not been thoroughly examined. Debates over the role of diagnostic substitution also continue. California has been an important test case in these controversies. The objective of this study was to determine the extent to which the increased prevalence of autism in California has been driven by changes in diagnostic practices, diagnostic substitution and diagnostic accretion.
METHODS: Retrospective case record examination of 7003 patients born before 1987 with autism who were enrolled with the California Department of Developmental Services between 1992 and 2005 was carried out. Of principal interest were 631 patients with a sole diagnosis of mental retardation (MR) who subsequently acquired a diagnosis of autism. The outcome of interest was the probability of acquiring a diagnosis of autism as a result of changes in diagnostic practices was calculated. The probability of diagnostic change is then used to model the proportion of the autism caseload arising from changing diagnostic practices.
RESULTS: The odds of a patient acquiring an autism diagnosis were elevated in periods in which the practices for diagnosing autism changed. The odds of change in years in which diagnostic practices changed were 1.68 [95% confidence interval (CI) 1.11-2.54], 1.55 (95% CI 1.03-2.34), 1.58 (95% CI 1.05-2.39), 1.82 (95% CI 1.23-2.7) and 1.61 (95% CI 1.09-2.39). Using the probability of change between 1992 and 2005 to generalize to the population with autism, it is estimated that 26.4% (95% CI 16.25-36.48) of the increased autism caseload in California is uniquely associated with diagnostic change through a single pathway--individuals previously diagnosed with MR.
CONCLUSION: Changes in practices for diagnosing autism have had a substantial effect on autism caseloads, accounting for one-quarter of the observed increase in prevalence in California between 1992 and 2005.

Entities:  

Mesh:

Year:  2009        PMID: 19737791      PMCID: PMC2800781          DOI: 10.1093/ije/dyp261

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  15 in total

1.  Is there an epidemic of autism?

Authors:  E Fombonne
Journal:  Pediatrics       Date:  2001-02       Impact factor: 7.124

2.  The prevalence of autism.

Authors:  Eric Fombonne
Journal:  JAMA       Date:  2003-01-01       Impact factor: 56.272

3.  National autism prevalence trends from United States special education data.

Authors:  Craig J Newschaffer; Matthew D Falb; James G Gurney
Journal:  Pediatrics       Date:  2005-03       Impact factor: 7.124

Review 4.  Incidence of autism spectrum disorders: changes over time and their meaning.

Authors:  M Rutter
Journal:  Acta Paediatr       Date:  2005-01       Impact factor: 2.299

5.  The contribution of diagnostic substitution to the growing administrative prevalence of autism in US special education.

Authors:  Paul T Shattuck
Journal:  Pediatrics       Date:  2006-04       Impact factor: 7.124

6.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

7.  Three Reasons Not to Believe in an Autism Epidemic.

Authors:  Morton Ann Gernsbacher; Michelle Dawson; H Hill Goldsmith
Journal:  Curr Dir Psychol Sci       Date:  2005-04

8.  Autism and diagnostic substitution: evidence from a study of adults with a history of developmental language disorder.

Authors:  Dorothy V M Bishop; Andrew J O Whitehouse; Helen J Watt; Elizabeth A Line
Journal:  Dev Med Child Neurol       Date:  2008-03-31       Impact factor: 5.449

9.  The changing prevalence of autism in California.

Authors:  Lisa A Croen; Judith K Grether; Jenny Hoogstrate; Steve Selvin
Journal:  J Autism Dev Disord       Date:  2002-06

Review 10.  The epidemiology of autistic spectrum disorders: is the prevalence rising?

Authors:  Lorna Wing; David Potter
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2002
View more
  116 in total

Review 1.  Maternal SSRIs experience and risk of ASD in offspring: a review.

Authors:  Zainab Fatima; Aqeela Zahra; Maria Ghouse; Xu Wang; Zonghui Yuan
Journal:  Toxicol Res (Camb)       Date:  2018-07-11       Impact factor: 3.524

2.  The prevalence puzzle: Autism counts.

Authors:  Karen Weintraub
Journal:  Nature       Date:  2011-11-02       Impact factor: 49.962

3.  Effects of risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problems.

Authors:  Lawrence Scahill; Christopher J McDougle; Michael G Aman; Cynthia Johnson; Benjamin Handen; Karen Bearss; James Dziura; Eric Butter; Naomi G Swiezy; L Eugene Arnold; Kimberly A Stigler; Denis D Sukhodolsky; Luc Lecavalier; Stacie L Pozdol; Roumen Nikolov; Jill A Hollway; Patricia Korzekwa; Allison Gavaletz; Arlene E Kohn; Kathleen Koenig; Stacie Grinnon; James A Mulick; Sunkyung Yu; Benedetto Vitiello
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2011-12-23       Impact factor: 8.829

4.  Social influence and the autism epidemic.

Authors:  Ka-Yuet Liu; Marissa King; Peter S Bearman
Journal:  AJS       Date:  2010-03

5.  Child health in the United States: recent trends in racial/ethnic disparities.

Authors:  Neil K Mehta; Hedwig Lee; Kelly R Ylitalo
Journal:  Soc Sci Med       Date:  2012-09-17       Impact factor: 4.634

Review 6.  Stem cells and modeling of autism spectrum disorders.

Authors:  Beatriz C G Freitas; Cleber A Trujillo; Cassiano Carromeu; Marianna Yusupova; Roberto H Herai; Alysson R Muotri
Journal:  Exp Neurol       Date:  2012-10-02       Impact factor: 5.330

7.  Brief Report: Gender and Age of Diagnosis Time Trends in Children with Autism Using Australian Medicare Data.

Authors:  Tamara May; Katrina Williams
Journal:  J Autism Dev Disord       Date:  2018-12

Review 8.  Meta-Analysis of the Association between GABA Receptor Polymorphisms and Autism Spectrum Disorder (ASD).

Authors:  Manijeh Mahdavi; Majid Kheirollahi; Roya Riahi; Fariborz Khorvash; Mehdi Khorrami; Maryam Mirsafaie
Journal:  J Mol Neurosci       Date:  2018-05-03       Impact factor: 3.444

Review 9.  Neuroimaging-based methods for autism identification: a possible translational application?

Authors:  Alessandra Retico; Michela Tosetti; Filippo Muratori; Sara Calderoni
Journal:  Funct Neurol       Date:  2014 Oct-Dec

Review 10.  Biomarkers in autism spectrum disorder: the old and the new.

Authors:  Barbara Ruggeri; Ugis Sarkans; Gunter Schumann; Antonio M Persico
Journal:  Psychopharmacology (Berl)       Date:  2013-10-06       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.